Literature DB >> 20526966

How to do research fairly in an unjust world.

Angela J Ballantyne1.   

Abstract

International research, sponsored by for-profit companies, is regularly criticised as unethical on the grounds that it exploits research subjects in developing countries. Many commentators agree that exploitation occurs when the benefits of cooperative activity are unfairly distributed between the parties. To determine whether international research is exploitative we therefore need an account of fair distribution. Procedural accounts of fair bargaining have been popular solutions to this problem, but I argue that they are insufficient to protect against exploitation. I argue instead that a maximin principle of fair distribution provides a more compelling normative account of fairness in relationships characterised by extreme vulnerability and inequality of bargaining potential between the parties. A global tax on international research would provide a mechanism for implementing the maximin account of fair benefits. This model has the capacity to ensure fair benefits and thereby prevent exploitation in international research.

Entities:  

Mesh:

Year:  2010        PMID: 20526966     DOI: 10.1080/15265161.2010.482629

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  11 in total

1.  Involving Communities in Deciding What Benefits They Receive in Multinational Research.

Authors:  David Wendler; Seema Shah
Journal:  J Med Philos       Date:  2015-07-29

Review 2.  What Do the Various Principles of Justice Mean Within the Concept of Benefit Sharing?

Authors:  Bege Dauda; Yvonne Denier; Kris Dierickx
Journal:  J Bioeth Inq       Date:  2016-01-29       Impact factor: 1.352

3.  Beyond Fair Benefits: Reconsidering Exploitation Arguments Against Organ Markets.

Authors:  Julian J Koplin
Journal:  Health Care Anal       Date:  2018-03

4.  Practical and political problems with a global research tax.

Authors:  David B Resnik
Journal:  Am J Bioeth       Date:  2010-06       Impact factor: 11.229

5.  Pharmacogenomic technologies: a necessary "luxury" for better global public health?

Authors:  Catherine Olivier; Bryn Williams-Jones
Journal:  Global Health       Date:  2011-08-24       Impact factor: 4.185

6.  Ethical considerations for clinical trials in inflammatory bowel disease.

Authors:  David T Rubin; Samuel Becker; Mark Siegler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

Review 7.  Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective.

Authors:  Pamela Andanda; Jane Wathuta
Journal:  Med Health Care Philos       Date:  2018-03

8.  Shared challenges in psychiatric research in India and Sri Lanka.

Authors:  Harischandra Gambheera; Shehan Williams
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

9.  Benefit sharing: an exploration on the contextual discourse of a changing concept.

Authors:  Bege Dauda; Kris Dierickx
Journal:  BMC Med Ethics       Date:  2013-09-12       Impact factor: 2.652

10.  Protections for clinical trials in low and middle income countries need strengthening not weakening.

Authors:  Rafael Dal-Ré; Paul Ndebele; Elizabeth Higgs; Nelson Sewankambo; David Wendler
Journal:  BMJ       Date:  2014-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.